Scott Schoenhaus
Stock Analyst at Keybanc
(2.12)
# 2,945
Out of 4,996 analysts
112
Total ratings
39.8%
Success rate
-3.86%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Overweight | $14 → $12 | $6.43 | +86.63% | 4 | Aug 6, 2025 | |
| SLP Simulations Plus | Downgrades: Sector Weight | n/a | $14.89 | - | 5 | Jul 15, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $45 → $60 | $48.46 | +23.81% | 2 | Jul 14, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $106 → $93 | $62.71 | +48.30% | 1 | Jul 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $70 | $74.40 | -5.91% | 4 | Jul 14, 2025 | |
| CERT Certara | Maintains: Overweight | $18 → $15 | $11.80 | +27.12% | 5 | Jul 14, 2025 | |
| ALB Albemarle | Maintains: Overweight | $95 → $87 | $88.10 | -1.25% | 1 | Jul 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $5 → $10 | $4.74 | +110.97% | 6 | Jul 14, 2025 | |
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $19.30 | +65.80% | 5 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $23.62 | +18.54% | 7 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $52 → $50 | $60.99 | -18.02% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $96.53 | +3.59% | 5 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.80 | +78.57% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $9 | $2.73 | +229.67% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $290.27 | -12.15% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $4.72 | +111.86% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $4.04 | +48.51% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.78 | +61.87% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $3.25 | +238.46% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.46 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $30.72 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $8.16 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $179.56 | +39.23% | 2 | Apr 16, 2021 |
LifeMD
Aug 6, 2025
Maintains: Overweight
Price Target: $14 → $12
Current: $6.43
Upside: +86.63%
Simulations Plus
Jul 15, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $14.89
Upside: -
Hinge Health
Jul 14, 2025
Maintains: Overweight
Price Target: $45 → $60
Current: $48.46
Upside: +23.81%
Eastman Chemical Company
Jul 14, 2025
Maintains: Overweight
Price Target: $106 → $93
Current: $62.71
Upside: +48.30%
Doximity
Jul 14, 2025
Maintains: Overweight
Price Target: $65 → $70
Current: $74.40
Upside: -5.91%
Certara
Jul 14, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $11.80
Upside: +27.12%
Albemarle
Jul 14, 2025
Maintains: Overweight
Price Target: $95 → $87
Current: $88.10
Upside: -1.25%
AbCellera Biologics
Jul 14, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $4.74
Upside: +110.97%
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $19.30
Upside: +65.80%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $23.62
Upside: +18.54%
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $60.99
Upside: -18.02%
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $96.53
Upside: +3.59%
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $2.80
Upside: +78.57%
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.73
Upside: +229.67%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $290.27
Upside: -12.15%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $4.72
Upside: +111.86%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $4.04
Upside: +48.51%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.78
Upside: +61.87%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $3.25
Upside: +238.46%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $21.46
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $30.72
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $8.16
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $179.56
Upside: +39.23%